VivoSim Labs (VIVS) EBT Margin Growth (3y) (2014 - 2026)
VivoSim Labs (VIVS) EBT Margin Growth (3y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | -484.00 |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 132.00 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 6,685.00 |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -2,054.00 |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 8,006.00 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 9,980.00 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -9,922.00 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 31,363.00 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | -5,319.00 |
| 10 | VivoSim Labs | 1.49 Mn | 1.49 Mn | - | -981,044.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.14 Mn |
| Mar 31, 2026 | -328,627.00 |
| Dec 31, 2025 | -859,615.00 |
| Sep 30, 2025 | -504,643.00 |
| Mar 31, 2025 | -502,707.00 |
| Dec 31, 2022 | -77,842.00 |
| Sep 30, 2022 | -387,502.00 |
| Mar 31, 2022 | 88,731.00 |
| Dec 31, 2019 | -40,628.00 |
| Sep 30, 2019 | 58,755.00 |
| Jun 30, 2019 | -5,466.00 |
| Mar 31, 2019 | 50,265.00 |
| Dec 31, 2018 | -3.07 Mn |
| Sep 30, 2018 | -11.29 Mn |
| Jun 30, 2018 | 336,139.00 |
| Mar 31, 2018 | 230,844.00 |
| Dec 31, 2017 | 1.57 Mn |
| Sep 30, 2017 | 995,109.00 |
| Jun 30, 2017 | 2.86 Mn |
| Sep 30, 2016 | 9.86 Mn |